BACKGROUND: There are no suitably powered epidemiological studies of 'transient azotaemia' (TA). The objective of this study was to describe the epidemiology of TA and its independent association with hospital mortality. We hypothesized that TA would be associated with an independent increase in the risk of death. METHODS: We retrospectively studied all patients admitted to a university-affiliated hospital in Australia between January 2000 and December 2002. Patients were excluded if they were <15 years old, were on chronic dialysis, had kidney transplant or if their length of hospital stay was <24 hours. We defined TA as rapidly recovering acute kidney injury (AKI) (return to no-AKI risk, injury, failure, loss, end stage (RIFLE) class within 72 hours of onset). We performed descriptive and comparative statistical analysis of data. The primary outcome of the study was the association between TA and hospital mortality in multivariate logistic regression analysis. RESULTS: Among 20 126 study patients, 3641 (18.1%) had AKI according to the RIFLE criteria and 1600 had AKI, which recovered during their hospital stay. Recovery of AKI occurred most commonly within 1 day after diagnosis (37.7%, n = 603). Furthermore, 1172 patients (73.3%) who recovered from AKI did so within 3 days (TA). After correcting for confounding factors, compared with patients without AKI, patients with TA had a significantly higher odds ratio for hospital mortality (2.26; 95% confidence interval: 1.85-2.76). CONCLUSIONS: Transient azotaemia is common in hospital patients, represents close to a third of all cases of AKI and is independently associated with a significantly higher risk of death.
BACKGROUND: There are no suitably powered epidemiological studies of 'transient azotaemia' (TA). The objective of this study was to describe the epidemiology of TA and its independent association with hospital mortality. We hypothesized that TA would be associated with an independent increase in the risk of death. METHODS: We retrospectively studied all patients admitted to a university-affiliated hospital in Australia between January 2000 and December 2002. Patients were excluded if they were <15 years old, were on chronic dialysis, had kidney transplant or if their length of hospital stay was <24 hours. We defined TA as rapidly recovering acute kidney injury (AKI) (return to no-AKI risk, injury, failure, loss, end stage (RIFLE) class within 72 hours of onset). We performed descriptive and comparative statistical analysis of data. The primary outcome of the study was the association between TA and hospital mortality in multivariate logistic regression analysis. RESULTS: Among 20 126 study patients, 3641 (18.1%) had AKI according to the RIFLE criteria and 1600 had AKI, which recovered during their hospital stay. Recovery of AKI occurred most commonly within 1 day after diagnosis (37.7%, n = 603). Furthermore, 1172 patients (73.3%) who recovered from AKI did so within 3 days (TA). After correcting for confounding factors, compared with patients without AKI, patients with TA had a significantly higher odds ratio for hospital mortality (2.26; 95% confidence interval: 1.85-2.76). CONCLUSIONS: Transient azotaemia is common in hospital patients, represents close to a third of all cases of AKI and is independently associated with a significantly higher risk of death.
Authors: Michael Haase; Prasad Devarajan; Anja Haase-Fielitz; Rinaldo Bellomo; Dinna N Cruz; Gebhard Wagener; Catherine D Krawczeski; Jay L Koyner; Patrick Murray; Michael Zappitelli; Stuart L Goldstein; Konstantinos Makris; Claudio Ronco; Johan Martensson; Claes-Roland Martling; Per Venge; Edward Siew; Lorraine B Ware; T Alp Ikizler; Peter R Mertens Journal: J Am Coll Cardiol Date: 2011-04-26 Impact factor: 24.094
Authors: Pamela D Winterberg; Yanxia Wang; Keng-Mean Lin; John R Hartono; Glenn T Nagami; Xin J Zhou; John M Shelton; James A Richardson; Christopher Y Lu Journal: Am J Physiol Renal Physiol Date: 2013-05-08
Authors: Jose Calvo Broce; Lori Lyn Price; Orfeas Liangos; Katrin Uhlig; Bertrand L Jaber Journal: Clin J Am Soc Nephrol Date: 2011-06-23 Impact factor: 8.237
Authors: Rossella Marino; Joachim Struck; Oliver Hartmann; Alan S Maisel; Miriam Rehfeldt; Laura Magrini; Olle Melander; Andreas Bergmann; Salvatore Di Somma Journal: J Nephrol Date: 2014-12-09 Impact factor: 3.902
Authors: Bixiao Zhao; Qiongshi Lu; Yuwei Cheng; Justin M Belcher; Edward D Siew; David E Leaf; Simon C Body; Amanda A Fox; Sushrut S Waikar; Charles D Collard; Heather Thiessen-Philbrook; T Alp Ikizler; Lorraine B Ware; Charles L Edelstein; Amit X Garg; Murim Choi; Jennifer A Schaub; Hongyu Zhao; Richard P Lifton; Chirag R Parikh Journal: Am J Respir Crit Care Med Date: 2017-02-15 Impact factor: 21.405